BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2278719)

  • 1. Failure of preventing 5-fluorouracil cardiotoxicity by prophylactic treatment with verapamil.
    Eskilsson J; Albertsson M
    Acta Oncol; 1990; 29(8):1001-3. PubMed ID: 2278719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiotoxicity of 5-fluorouracil.
    Collins C; Weiden PL
    Cancer Treat Rep; 1987; 71(7-8):733-6. PubMed ID: 3300968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of patients with persistent chest pain and ST-segment elevation during 5-fluorouracil treatment: report about two cases.
    Mafrici A; Alberti A; Corrada E; Ferrari S; Marenna B
    Ital Heart J; 2003 Dec; 4(12):895-9. PubMed ID: 14976858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cardiotoxicity of 5-fluorouracil: report of 6 cases].
    Timour Q; Lombard-Bohas C; Slim R; Barel C; Bui-Xuan B; Tabib A; Bricca G; Malonne H; Vial T; Iordescu D; Descotes J
    Therapie; 2002; 57(3):302-6. PubMed ID: 12422546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse cardiac effects during induction chemotherapy treatment with cis-platin and 5-fluorouracil.
    Eskilsson J; Albertsson M; Mercke C
    Radiother Oncol; 1988 Sep; 13(1):41-6. PubMed ID: 3187073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptomatic cardiotoxicity associated with 5-fluorouracil.
    Meyer CC; Calis KA; Burke LB; Walawander CA; Grasela TH
    Pharmacotherapy; 1997; 17(4):729-36. PubMed ID: 9250550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic options in patients with 5-fluorouracil-associated cardiotoxicity.
    Cianci G; Morelli MF; Cannita K; Morese R; Ricevuto E; Di Rocco ZC; Porzio G; Lanfiuti Baldi P; Ficorella C
    Br J Cancer; 2003 May; 88(10):1507-9. PubMed ID: 12771913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cardiotoxicity of 5-fluorouracil].
    Pan L; Yang X; Song H
    Zhonghua Fu Chan Ke Za Zhi; 1996 Feb; 31(2):86-9. PubMed ID: 8758800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiotoxicity of 5-fluorouracil in 1350 patients with no prior history of heart disease.
    Tsibiribi P; Descotes J; Lombard-Bohas C; Barel C; Bui-Xuan B; Belkhiria M; Tabib A; Timour Q
    Bull Cancer; 2006 Mar; 93(3):E27-30. PubMed ID: 16567310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer.
    Hitt R; López-Pousa A; Martínez-Trufero J; Escrig V; Carles J; Rizo A; Isla D; Vega ME; Martí JL; Lobo F; Pastor P; Valentí V; Belón J; Sánchez MA; Chaib C; Pallarés C; Antón A; Cervantes A; Paz-Ares L; Cortés-Funes H
    J Clin Oncol; 2005 Dec; 23(34):8636-45. PubMed ID: 16275937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cardiac side effects of 5-fluorouracil].
    May D; Wandl U; Becher R; Niederle N; Schmidt CG
    Dtsch Med Wochenschr; 1990 Apr; 115(16):618-21. PubMed ID: 2328669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-line protracted venous infusion fluorouracil with CisDDP or carboplatin in advanced colorectal cancer.
    Garcia-Giralt E; Beuzeboc P; Deffontaines D; Diéras V; Dorval T; Jouve M; Palangie T; Scholl S; Pouillart P
    J Infus Chemother; 1996; 6(3):149-51. PubMed ID: 9229328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acute cardiac toxicity of 5-fluorouracil: pharmacokinetic correlation].
    Gamelin E; Gamelin L; Larra F; Turcant A; Alain P; Maillart P; Allain YM; Minier JF; Dubin J
    Bull Cancer; 1991; 78(12):1147-53. PubMed ID: 1786427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Risk of cardiotoxicity of combination treatment radiotherapy and chemotherapy of locally advanced breast carcinoma stage III].
    Bustová I
    Klin Onkol; 2009; 22(1):17-21. PubMed ID: 19534435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of high-dose leucovorin and 5-fluorouracil chemotherapy regimen on P wave duration and dispersion.
    Ceyhan C; Meydan N; Barutca S; Tekten T; Onbasili AO; Ozturk B; Unal S; Bayrak I
    J Clin Pharm Ther; 2004 Jun; 29(3):267-71. PubMed ID: 15153089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute heart failure after treatment with 5-fluorouracil.
    Georgieva S; Kinova E; Iordanov V; Gudev A; Tzekova V; Velikova M
    J BUON; 2007; 12(1):113-6. PubMed ID: 17436411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cardiotoxicity induced by 5-fluorouracil. Review of the literature].
    Blázquez Encinar JC; Martín Jiménez M; Díaz-Rubio García E; Almenarez J
    Rev Clin Esp; 1989 Mar; 184(5):249-51. PubMed ID: 2672149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Case of 5-Fluorouracil-Induced Cardiac Arrest.
    Ray JC; Cho P; Dragon M; Graham CG
    J Emerg Med; 2016 Jan; 50(1):e1-6. PubMed ID: 26482827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiotoxicity of de Gramont's regimen: incidence, clinical characteristics and long-term follow-up.
    Meydan N; Kundak I; Yavuzsen T; Oztop I; Barutca S; Yilmaz U; Alakavuklar MN
    Jpn J Clin Oncol; 2005 May; 35(5):265-70. PubMed ID: 15855175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of 5-fluorouracil cardiotoxicity simulating acute myocardial infarction.
    Mizuno Y; Hokamura Y; Kimura T; Kimura Y; Kaikita K; Yasue H
    Jpn Circ J; 1995 May; 59(5):303-7. PubMed ID: 7596036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.